• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-L
Device Problems Material Too Rigid or Stiff (1544); Insufficient Information (3190)
Patient Problem Thrombocytopenia (4431)
Event Date 10/22/2023
Event Type  Injury  
Event Description
The manufacturer was informed of the following event through mantra study database.Reportedly, a perceval plus valve size l was implanted in the patient on (b)(6) 2023.Concomitant procedure was cabg which was performed before implant.Based on information received, patient got thrombocytopenia on (b)(6) 2023.As such, platelets transfusion was performed.As reported, the patient's clinical history included cad, systemic hypertension, diabetes mellitus type ii - insulin dependent, dyslipidemia, and stroke.Patient was nyha class ii.Based on the information reported, aspirin was stopped before implant, platelet count was reported as (152 109 /l) at pre-op, and (72 109 /l) at discharge.Patient was discharged on (b)(6) 2023.Based on the tee and tte, no functionality issue with the valve was noted after procedure, and no regurgitation was noted at the time of discharge.Mean gradient was11 mmhg.
 
Manufacturer Narrative
H3 other text : still implanted.
 
Manufacturer Narrative
The manufacturing and material records for the perceval plus heart valve, model # pvf-l, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve has been manufactured and controlled in accordance with the specifications for a (model # pvf-l) perceval plus heart valve at the time of manufacture and release.Based on the information available, it is not possible to draw a definitive root cause for the reported event.However, per the document review performed, no manufacturing deficiencies were identified with the perceval valve involved in the event.Thrombocytopenia (tcp) in cardiac surgery is a very well-known phenomenon.The etiology is multi-factorial due to multiple factors including hemodilution, blood loss with volume repletion with platelet-poor fluids, platelet activation, consumption and destruction due to contact with foreign surfaces.Tcp following aortic valve replacement (avr) is also a common phenomenon.Patient factors and prolonged extracorporeal circulation all being recognized predictors of tcp following cardiac surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key18203399
MDR Text Key328885315
Report Number3004478276-2023-00204
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000818
UDI-Public(01)00896208000818(240)PVF-L(17)270611
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-L
Device Catalogue NumberPVF-L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/11/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age77 YR
Patient SexMale
Patient Weight62 KG
-
-